Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one
Clinical trial NCT06230900 · COMPLETED
Trial details
- NCT number
- NCT06230900
- Sponsor
- Wageningen University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-05
- Primary completion
- 2025-04-19
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.